Article

Lipid Nanoparticles for the Delivery of CRISPR/Cas9 Machinery to Enable Site-Specific…

medRxiv · 2025 · Foley, R. A.; Ayoub, P. G.; Sinha, V.; Juett, C.; Sanoyca, A.; Duggan, E. C.; Lathrop, L. E.; Bhatt, P.; Coote, K.; Illek, B.; Gomperts, B. N.; Kohn, D. B.; Jonas, S. J.

Key facts

Title Lipid Nanoparticles for the Delivery of CRISPR/Cas9 Machinery to Enable Site-Specific Integration of CFTR and Mutation-Agnostic Disease Rescue
First author Foley, R. A.; Ayoub, P. G.; Sinha, V.; Juett, C.; Sanoyca, A.; Duggan, E. C.; Lathrop, L. E.; Bhatt, P.; Coote, K.; Illek, B.; Gomperts, B. N.; Kohn, D. B.; Jonas, S. J.
Journal medRxiv
Published Jan 1, 2025
DOI 10.1101/2025.01.22.633938
Devices mentioned K182002, K800781, K973350, K990827
Product codes mentioned JLX, KIS, KQP, MQL

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature